Ameritas Investment Partners, Inc. Adaptive Biotechnologies Corp Transaction History
Ameritas Investment Partners, Inc.
- $3.05 Billion
- Q2 2025
A detailed history of Ameritas Investment Partners, Inc. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 15,258 shares of ADPT stock, worth $193,166. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,258
Previous 11,286
35.19%
Holding current value
$193,166
Previous $83,000
113.25%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ADPT
# of Institutions
263Shares Held
150MCall Options Held
168KPut Options Held
25.2K-
Viking Global Investors LP30MShares$380 Million1.11% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$148 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$143 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY6.26MShares$79.2 Million1.68% of portfolio
-
Nikko Asset Management Americas, Inc.4.3MShares$54.4 Million0.53% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.81B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...